根据美国证券交易委员会(SEC)披露，沙特最大规模主权财富基金——公共投资基金(PIF)递交了截至2025年3月31日的第一季度美股持仓报告(13F)。 芯片设计领域领导者ARM(ARM.US)看涨期权位列第五，持仓约890万股，持仓市值约为9.5亿美元，占投资组合比例为3.72%，持仓数量环比降低9.06%。 | BY CHANGE IN % PORTFOLIO | BY LARGEST VALUE | BY CHANGE IN % PORT | | --- | --- | --- | | Name | % Change | Name | | SYK Stryker Corp (CALL) | 0.46% | BKNG Booking Holo | | HCA HCA Healthcare Inc (CALL) | 0.41% | SBUX Starbucks Co | | ZTS Zoetis, Inc (CALL) | 0.4% | PYPL PayPal Holdin | | ASML ASML Holding NV (CALL) | 0.31% | ARM Arm Holdings | | BAC ...

Core Viewpoint - Encompass Health Corporation (EHC) is expanding its operations by planning to build a new 50-bed inpatient rehabilitation hospital in Apollo Beach, Florida, to enhance access to advanced rehabilitation services for patients recovering from serious medical conditions [1][2]. Company Expansion Plans - The new facility in Apollo Beach is part of EHC's broader growth strategy in high-demand markets, aiming to bring personalized rehabilitative care closer to patients and strengthen the brand's visibility in a growing community [2]. - EHC currently operates 167 hospitals across 38 states and Puerto Rico, with plans to open seven de novo hospitals and add 340 beds in 2025, along with a 50-bed satellite hospital [4]. - The company aims to inaugurate six to ten de novo hospitals each year from 2023 to 2027, with annual bed additions ranging from 80 to 120 [5]. Market Position and Performance - EHC's expansion reflects confidence in the profitability of entering underserved, high-growth regions, positioning the company to capture a larger share of the post-acute care market in Florida [3]. - Shares of Encompass Health have increased by 26.6% year-to-date, outperforming the industry growth of 4.2% [6]. - The company holds a Zacks Rank 1 (Strong Buy), indicating strong market confidence [7].

Group 1: Economic Observations - Nashville has emerged as a new economic hub in the U.S., with GDP growth from $144 billion to $204 billion from 2018 to 2023, marking a national growth rate of 3.1% for 2024 [11] - The city has attracted manufacturing companies due to tax incentives, with Nissan's U.S. headquarters located there [9] - Nashville's economy is bolstered by major employers such as HCA, Amazon, and Oracle, contributing to job creation and urban development [11] Group 2: Cultural Insights - Nashville is recognized as a cultural center, particularly for country music, and has become a popular destination for events like bachelor parties [11] - The local population exhibits a strong sense of community and cultural identity, with a significant presence of Christian faith reflected in the number of churches [13][15] Group 3: Investment Perspectives - U.S. LPs (Limited Partners) express confidence in the long-term attractiveness of the U.S. economy, viewing current market conditions as a reset rather than a crisis [41] - There is a notable trend of capital allocation towards quality names in response to tariff impacts, with expectations of increased domestic production from companies like Ford and GM [38] - The investment landscape is characterized by a focus on tax optimization strategies, with many funds prioritizing long-term holdings to minimize tax liabilities [43]

Core Viewpoint - Acadia Healthcare Company, Inc. (ACHC) is expected to report first-quarter 2025 results on May 12, with earnings estimated at 42 cents per share and revenues at $770.5 million, indicating a year-over-year earnings decline of 50% but a slight revenue growth of 0.3% [1][2]. Financial Estimates - First-quarter earnings estimates have declined by 8 cents per share over the past 60 days, reflecting a significant year-over-year decrease [2]. - For the full year 2025, the revenue estimate for Acadia Healthcare is $3.33 billion, representing a year-over-year increase of 5.7%, while the EPS estimate is $2.76, indicating a decline of 16.4% year-over-year [2]. Recent Performance - Acadia Healthcare has beaten earnings estimates in three of the last four quarters, with an average surprise of negative 0.4% [3]. Earnings Prediction Model - The current model does not predict an earnings beat for Acadia Healthcare, as it has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell) [4]. Revenue Drivers - Revenue per patient day is estimated to rise by 2% year-over-year, and revenues from Residential Treatment Centers are expected to increase by 9.7% from $85.6 million a year ago [6]. - U.S. same-facility admissions are projected to show a marginal increase, while revenues from Specialty Treatment Facilities are expected to rise by 0.1% from $143.8 million [7]. Expense Concerns - Rising expenses are anticipated to impact profit levels, with total expenses expected to increase by more than 11% due to higher salaries, wages, benefits, and other operating costs [8]. - Supply costs are also expected to rise due to increased utilization [8]. Revenue Declines in Specific Areas - Revenues from Acute Inpatient Psychiatric Facilities are projected to decrease by 1.3% from $401.1 million, and same-facility patient days are expected to decline by 1.1% year-over-year [9]. - Comprehensive Treatment Centers' revenues are estimated to fall by 0.5% from $132.2 million [9].

Core Viewpoint - The Ensign Group, Inc. (ENSG) reported strong first-quarter 2025 results, with increased occupancy rates and patient days contributing to revenue growth, although rising expenses partially offset the gains [1][2][3]. Financial Performance - Adjusted earnings per share (EPS) for Q1 2025 were $1.52, exceeding the Zacks Consensus Estimate by 1.3% and reflecting a year-over-year increase of 16.9% [2]. - Operating revenues reached $1.2 billion, marking a 16.1% year-over-year growth and beating the consensus estimate by 0.2% [2]. - Adjusted net income improved 18% year over year to $89 million, surpassing the estimate of $88.3 million [3]. Segment Performance - Skilled Services segment revenues grew 15.9% year over year to $1.12 billion, slightly missing the Zacks Consensus Estimate but exceeding internal estimates [4]. - Rental revenues from the Standard Bearer segment totaled $28.4 million, up 27.9% year over year, driven by buyouts [5]. Operational Metrics - Same-facilities occupancy improved by 230 basis points, while transitioning-facilities occupancy expanded by 400 basis points year over year [3]. - Total expenses increased by 15.5% year over year to $1.07 billion, higher than the estimate of $1.06 billion [3]. Cash and Debt Position - As of March 31, 2025, cash and cash equivalents were $282.7 million, down 39.2% from the end of 2024 [6]. - Long-term debt (less current maturities) was $140.6 million, a decrease of 0.7% from December 31, 2024 [7]. Capital Deployment - The company repurchased shares worth $10.8 million and paid dividends totaling $3.6 million in Q1 2025 [9]. 2025 Outlook - Revenue guidance for 2025 has been revised to a range of $4.89-$4.94 billion, indicating a 15.4% improvement from 2024 [10]. - Adjusted EPS is forecasted between $6.22 and $6.38 for 2025, reflecting a 14.5% growth from the previous year [10].

Core Viewpoint - The technology sector has significantly increased share buyback activities, with S&P 500 tech companies spending $253 billion on buybacks in 2024, representing nearly 27% of total buyback spending across all sectors [1]. Group 1: Company Buyback Announcements - KLA announced a $5 billion increase to its share buyback authorization, bringing its total buyback capacity to just under $5.5 billion, which is nearly 6% of its market capitalization [4]. - Dell Technologies revealed a $10 billion increase to its share repurchase authorization, which is approximately 15% of its $66 billion market cap [6][7]. - Alphabet announced a substantial $70 billion share buyback program, which represents about 3.5% of its market cap of around $2 trillion [10][11]. Group 2: Dividend Increases - KLA increased its quarterly dividend by almost 12%, with an indicated yield of around 1.1% [5]. - Dell Technologies announced an 18% increase to its quarterly dividend, now just under $0.53 per share, yielding around 2.2% [8]. - Alphabet's dividend increase was modest at 5%, with a quarterly dividend of $0.21, resulting in a yield of just over 0.5% [12]. Group 3: Market Sentiment and Analyst Ratings - KLA is recognized as a leader in chip inspection and metrology equipment, with a MarketRank of 93rd percentile and a moderate buy rating [3]. - Dell Technologies holds a MarketRank of 100th percentile, indicating strong market sentiment with a projected earnings growth of 17.75% [7]. - Alphabet has a MarketRank of 80th percentile, with a moderate buy rating and projected earnings growth of 14.94% [11].

Core Viewpoint - Pediatrix Medical Group, Inc. is expected to report its first-quarter 2025 results on May 6, 2025, with earnings estimated at 25 cents per share and revenues at $454.5 million, indicating a year-over-year earnings increase of 25% but a revenue decrease of 8.2% [1][2]. Financial Estimates - The Zacks Consensus Estimate for Pediatrix Medical's total revenues for 2025 is $1.9 billion, reflecting a year-over-year decline of 6.6%. The EPS estimate for the current year stands at $1.55, suggesting a growth of 2.7% year-over-year [2]. - The earnings estimate for the first quarter has remained stable over the past 60 days, with the company having beaten consensus earnings estimates in the previous four quarters by an average surprise of 19.4% [2][3]. Earnings Prediction Model - The current model indicates that Pediatrix Medical has an Earnings ESP of 0.00% and a Zacks Rank of 2 (Buy), which does not strongly predict an earnings beat for the upcoming quarter [3]. Revenue Factors - The Zacks Consensus Estimate for first-quarter net patient service revenue indicates a 7.6% year-over-year decline, while hospital contract administrative fees are expected to decline by 10.7% from the previous year, impacting the company's top line [5]. - The same-facility revenue growth is estimated at 0.75%, with patient volume growth at 0% and net reimbursement growth at 0.75%. NICU patient days growth is projected at 1.9% [6]. Operating Expenses - The model estimates a more than 10% year-over-year decline in total operating expenses, attributed to lower practice salaries and benefits, practice supplies, and general administrative costs. The first-quarter interest expense is projected at $8 million, continuing a year-over-year decline [7]. - The adjusted net income for the first quarter is expected to be nearly $21 million, representing a significant increase from the same period last year [7].

Humana Inc. (HUM) reported first-quarter 2025 adjusted earnings of $11.58 per share, which outpaced the Zacks Consensus Estimate by 16%. The bottom line soared 60.2% year over year. (See the Zacks Earnings Calendar to stay ahead of market-making news.)Adjusted revenues improved 9.5% year over year to $32.1 billion. However, the top line missed the consensus mark by 0.3%. The quarterly results benefited on the back of strong premiums resulting from an expanding customer base in stand-alone prescription drug ...

Industry Overview - The Zacks Medical-Hospital industry consists of for-profit hospital companies providing various healthcare services, including acute care, rehabilitation, and psychiatric care [3] - Revenue generation is influenced by inpatient occupancy levels, medical services ordered, and outpatient procedure volumes [3] - Payments for services come from government programs like Medicare and Medicaid, managed care plans, private insurers, and directly from patients [3] Key Trends Shaping the Hospital Industry - Growing patient volumes are driven by the resumption of elective procedures post-pandemic, with the 65+ age group projected to increase from 17.3% in 2022 to 22.8% by 2050 [4] - Health spending is expected to reach $5.3 trillion by 2025, indicating strong demand for healthcare services [4] - Rising costs are a concern, but programs like the Affordable Care Act are anticipated to support continued growth [4] Managing Cost Pressures - Hospitals are facing rising expenses due to increased patient volumes and higher supply, labor, and benefit costs [5] - Strategies to counter these pressures include improving labor productivity, adopting cost-saving technologies, and enhancing operational efficiency [5] - Stabilizing patient volumes and renegotiated supplier contracts are expected to strengthen cost control [5] Embracing the Digital Shift - The healthcare sector is accelerating the adoption of AI, automation, and real-time analytics to enhance patient care and streamline operations [6] - Telehealth and telemedicine have become essential components of modern healthcare delivery, especially post-pandemic [6] Rising M&A Activity - Mergers and acquisitions are a key growth catalyst, with the industry expected to see continued deal activity driven by capacity expansion and efficiency goals [7] - Economic stabilization is likely to boost confidence in consolidation efforts within the fragmented industry [7] Zacks Industry Rank Shows Promise - The Zacks Medical-Hospital industry currently holds a Zacks Industry Rank of 27, placing it in the top 11% of nearly 250 Zacks industries [9] - Positive earnings outlook and revisions indicate optimism about the industry's growth potential [10] Industry Performance - The Zacks Medical-Hospital industry has outperformed the Zacks Medical sector and the S&P 500, gaining 3% year-to-date compared to the sector's 3.3% decline and the S&P 500's 6.4% fall [12] Industry's Current Valuation - The industry trades at a trailing 12-month EV/EBITDA ratio of 7.48X, significantly lower than the S&P 500's 16.31X and the sector's 10.48X [15] - Over the past five years, the industry has seen an EV/EBITDA range of 6.16X to 9.55X, with a median of 7.99X [15] Company Highlights - **Universal Health Services**: Focuses on acute care hospitals and outpatient centers, with growth driven by rising patient days and an expanding care network [18] - **Tenet Healthcare Corporation**: Operates a broad network of hospitals, with strong revenue growth in its Ambulatory Care segment [22] - **HCA Healthcare**: Positioned for growth with rising patient volumes and expansion into telemedicine [26] - **Community Health Systems**: Focuses on telehealth and hospital acquisitions to enhance specialty services and improve cost efficiency [28]